glp-1 agonist weight loss medications alternatives Comparing GLP‑1 Drugs With Other Methods: Diet & Exercise, Bariatric Surgery, and Lifestyle Programs -Pros & Cons GLP-1 Receptor Agonists for Obesity

The weight loss achieved varies by specific medication and dose: semaglutide 2.4 mg (Wegovy) produces approximately 15% weight loss, tirzepatide (Zepbound) up to 15-22%, and liraglutide 3 mg (Saxenda) about 5-8%

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

France holds a 17.1% share in 2025, expected to maintain 16.9% by 2035, supported by healthcare system demand and pharmaceutical applications, but facing challenges from market competition and healthcare budget considerations

Lets put it another way

Potential Mechanisms Several mechanisms may explain the association: Weight reduction leading to improved lung mechanics Reduced systemic inflammation Possible direct immunomodulatory effects of GLP-1 signaling However, the observational design means causality cannot be established